drugset / Trial / NCT03922542

Comparison of Standard vs. Accelerated Corneal Crosslinking

NCT03922542

Phase 2/3 Recruiting 510 enrolled Price Vision Group
RandomizedParallel-groupSingle-blindTreatment

Summary

The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.

Timeline

Start
2019-04-16
Primary completion
2026-06-01
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Background Riboflavin Other / unclassified 0.1 % Topical